Citation: I. Gurevich et W. Akerley, Treatment of the jaundiced patient with breast carcinoma - Case report andalternate therapeutic strategies, CANCER, 91(4), 2001, pp. 660-663
Authors:
Jaeckle, KA
Phuphanich, S
van den Bent, MJ
Aiken, R
Batchelor, T
Campbell, T
Fulton, D
Gilbert, M
Heros, D
Rogers, L
O'Day, SJ
Akerley, W
Allen, J
Baldas, S
Gertler, SZ
Greenberg, HS
LaFollette, S
Lesser, G
Mason, W
Recht, L
Wong, E
Chamberlain, MC
Cohn, A
Glantz, MJ
Guthell, JC
Maria, B
Moots, P
New, P
Russell, C
Shapiro, W
Swinnen, L
Howell, SB
Citation: Ka. Jaeckle et al., Intrathecal treatment of neoplastic meningitis due to breast cancer with aslow-release formulation of cytarabine, BR J CANC, 84(2), 2001, pp. 157-163
Authors:
King, TC
Akerley, W
Fan, AC
Moore, T
Mangray, S
Chen, MH
Safran, H
Citation: Tc. King et al., p53 mutations do not predict response to paclitaxel in metastatic nonsmallcell lung carcinoma, CANCER, 89(4), 2000, pp. 769-773
Authors:
Wanebo, HJ
Chougule, P
Ready, N
Koness, RJ
Akerley, W
McRae, R
Nigri, P
Leone, L
Webber, B
Safran, H
Citation: Hj. Wanebo et al., Preoperative paclitaxel, carboplatin, and radiation therapy in advanced head and neck cancer (stage III and IV), SEM RAD ONC, 9(2), 1999, pp. 77-84
Citation: Mj. Glantz et al., Principles and possibilities - Concurrent chemotherapy and radiotherapy inpatients with brain tumors, ONCOLOGY-NY, 13(10), 1999, pp. 78-82
Citation: H. Choy et al., Concurrent paclitaxel, carboplatin, and radiation therapy for locally advanced non-small cell lung cancer, SEMIN ONCOL, 26(1), 1999, pp. 36-43